LABOR
Kaiser nurses in Oakland walk off shift over staffing ratios
More than 2,400 nurses cite ratios the union says have not been honored since a March arbitration ruling.
POLICY
CMS finalizes rule narrowing observation status
After three years of advocacy by nursing groups, CMS will require hospitals to admit certain Medicare patients within 24 hours.
CLINICAL
Sepsis bundle compliance rose 18% at Mass General after EHR redesign
A two-year study finds that simplifying the order set, not adding alerts, drove the change.
BUSINESS
ICU travel pay collapses to pre-pandemic levels
Crisis-rate contracts that paid $5,000 a week in 2022 are now closing at $2,400.
NEWS
Inside the residency-match algorithm: what changed for 2026
A small tweak to the tie-break rules nudged hundreds of applicants into different programs.
LABOR
Portland paramedics vote to strike over response-time targets
The bargaining unit says the city's eight-minute target is not survivable on current staffing.
CLINICAL
FDA clears first non-opioid for moderate post-op pain
The drug, a Nav1.8 inhibitor, is the first new mechanism approved for acute pain in two decades.
More from the wire
- POLICYHow the Great Lakes states are quietly rebuilding rural OBs
- CLINICALVA pilots ambient AI scribes in 12 primary care clinics
- BUSINESSOR turnover times fell at three Midwest systems after black-belt redesign
- LABORCleveland Clinic begins phased rollout of self-scheduling for nursing shifts
- POLICYSenate HELP committee advances bipartisan bill on agency-fee disclosure
- CLINICALMayo's bloodstream-infection rate hits five-year low after central-line redesign
- BUSINESSNorthwell to lay off 1,400 administrative staff in $200M cost cut
- CLINICALGLP-1 prescribing climbs 22% among non-endocrinology providers
- POLICYCalifornia to require staffing-ratio audits across long-term-care facilities
- NEWSHow HCA's break-room redesign got nurses back to actual breaks
- NEWSScrubswire 100: the people shaping the floor in 2026
- CLINICALFDA panel split on extending RSV monoclonal to high-risk under-2s